| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Sep―25 |
Production of Recombinant Nucleocapsid Protein SARSN1 and Its Use for Assessing the Immune Response in Mice after Vaccination with a Live Probiotic Vaccine Containing the Coronavirus Nucleocapsid Protein |
T. V. Gupalova, E. A. Bormotova, G. F. Leontieva, T. A. Kramskaya, Yu.A. Desheva, A. N. Suvorov |
| 2 |
[GO] |
2025―Aug―29 |
Immunogenicity of DNA Vaccines against COVID-19 That Encode B- and T-Cell Immunogens after Combined Injection |
M. B. Borgoyakova, A. P. Rudometov, E. V. Starostina, A. M. Zadorozhny, E. V. Tigeeva, V. A. Yakovlev, D. N. Kisakov, L. A. Kisakova, L. I. Karpenko, A. A. Ilyichev |
| 3 |
[GO] |
2025―Jul―31 |
Study of the activity of plant-based preparations aganst SARS-CoV-2 and herpes simplex virus type 2 in vitro: a review of experimental data |
E. I. Kazachinskaia, L. N. Zibareva, Y. V. Kononova, A. M. Shestopalov, M. I. Voevoda, A. A. Chepurnov |
| 4 |
[GO] |
2025―Jul―18 |
Differentiation of the Cytokine Profile Modified by SARS-CoV-2 and Influenza Virus in an In Vitro Experiment |
N. V. Zaitseva, K. G. Starkova, O. V. Dolgikh, V. B. Alekseev |
| 5 |
[GO] |
2025―Jun―04 |
An MVA-based vector expressing the SARS-CoV-2 RBD fused to N protein induces neutralizing antibodies and T-cell immune response in mice |
D. V. Glazkova, R. R. Mintaev, O. V. Orlova, B. V. Belugin, G. A. Shipulin, E. V. Bogoslovskaya |
| 6 |
[GO] |
2025―May―31 |
Analysis of Increased False-Positive ELISA Results for HIV in the Blood of Donors Infected with SARS-CoV-2 |
H. Lin, Z. Wang, Q. Ren, Z. Cai, F. Ge, W. Yuan, T. Liao, Y. Wu, R. Peng, Y. Gu, Y. Kuang |
| 7 |
[GO] |
2025―Mar―27 |
Production of recombinant nucleocapsid protein SARSN1 and its use to assess the immune response after vaccination of mice with a live probiotic vaccine containing the nucleocapsid protein of coronavirus |
T. V. Gupalova, E. A. Bormotova, G. F. Leontieva, T. A. Kramskaya, Yu. A. Desheva, A. N. Suvorov |
| 8 |
[GO] |
2025―Feb―19 |
Immunogenicity of DNA vaccines against COVID-19, which encodes B and T cell immunogens with co-injection |
M. B. Borgoyakova, A. P. Rudometov, E. V. Starostina, A. M. Zadorozhny, E. V. Tigeeva, V. A. Yakovlev, D. N. Kisakov, L. A. Kisakova, L. I. Karpenko, A. A. Ilyichev |
| 9 |
[GO] |
2025―Jan―27 |
Differentiation of the cytokine profile modified by SARS-CoV-2 and Influenzavirus in an in vitro experiment |
N. V. Zaitseva, K. G. Starkova, O. V. Dolgikh, V. B. Alekseev |
| 10 |
[GO] |
2024―Dec―27 |
Analysis of increased false-positive ELISA results for HIV in blood of donors infected with SARS-CoV-2 |
H. Lin, Z. Wang, Q. Ren, Z. Cai, F. Ge, W. Yuan, T. Liao, Y. Wu, R. Peng, Y. Gu, Y. Kuang |
| 11 |
[GO] |
2024―Sep―28 |
Relationship between HLA-II Gene Polymorphisms and Immune Response in COVID-19 Survivors and Volunteers Vaccinated against This Infection |
V. I. Dubrovina, D. D. Bryukhova, K. M. Korytov, A. B. Pyatidesyatnikova, V. A. Vishnyakov, S. V. Balakhonov |
| 12 |
[GO] |
2024―Aug―02 |
Use of Adjuvant Compositions Based on Squalene Ensures Induction of Neutralizing Antibodies against SARS-CoV-2 |
E. A. Volosnikova, N. V. Volkova, V. V. Ermolaev, M. B. Borgoyakova, V. S. Nesmeyanova, A. V. Zaykovskaya, O. V. Pyankov, B. N. Zaitsev, S. V. Belenkaya, A. A. Isaeva, D. N. Shcherbakov |
| 13 |
[GO] |
2024―Jun―19 |
Correction to: Ratios between the Levels of IL-18, Free IL-18, and IL-18-Binding Protein Depending on the Severity and Outcome of COVID-19 |
A. A. Korotaeva, E. V. Samoilova, N. V. Pogosova, A. G. Fesenko, S. V. Evchenko, F. N. Paleev |
| 14 |
[GO] |
2024―Jun―19 |
Factors of Interleukin-6 Signaling in COVID-19 Patients with Lung Damage of Varying Degrees: A Pilot Study |
A. A. Korotaeva, E. V. Samoilova, N. V. Pogosova, D. T. Kuchiev, N. V. Gomyranova, F. N. Paleev |
| 15 |
[GO] |
2024―Jun―19 |
Endothelin Level in Menopausal Women with Comorbidity of the Acute Phase Middle Severity COVID-19 with Arterial Hypertension and Type 2 Diabetes Mellitus |
N. V. Semenova, E. V. Vyrupaeva, S. I. Kolesnikov, O. A. Nikitina, L. V. Rychkova, M. A. Darenskaya, A. G. Petrova, L. I. Kolesnikova |
| 16 |
[GO] |
2024―Jun―19 |
Analysis of T-cell and Humoral Immune Response to SARS-CoV-2 Antigens in Rituximab-Treated Patients with Rheumatoid Arthritis Vaccinated with Combined Vector Vaccine Gam-COVID-Vac |
V. O. Omelchenko, Yu. D. Kurochkina, A. V. Fedorova, V. S. Ovchinnikov, V. V. Koval, I. V. Bratko, E. A. Letyagina, M. A. Korolev |
| 17 |
[GO] |
2024―Jun―19 |
Delivery of Experimental mRNA Vaccine Encoding the RBD of SARS-CoV-2 by Jet Injection |
D. N. Kisakov, L. A. Kisakova, S. V. Sharabrin, V. A. Yakovlev, E. V. Tigeeva, M. B. Borgoyakova, E. V. Starostina, A. V. Zaikovskaya, A. P. Rudometov, N. B. Rudometova, L. I. Karpenko, A. A. Ilyichev |
| 18 |
[GO] |
2024―May―22 |
Relationship between HLA-II gene polymorphisms and immune response in COVID-19 survivors and volunteers vaccinated against this infection |
V. I. Dubrovina, D. D. Bryukhova, K. M. Korytov, A. B. Pyatidesyatnikova, V. A. Vishnyakov, S. V. Balakhonov |
| 19 |
[GO] |
2024―Mar―15 |
Ratios between the Levels of IL-18, Free IL-18, and IL-1β-Binding Protein Depending on the Severity and Outcome of COVID-19 |
A. A. Korotaeva, E. V. Samoilova, N. V. Pogosova, A. G. Fesenko, S. V. Evchenko, F. N. Paleev |
| 20 |
[GO] |
2024―Mar―15 |
Safety Assessment: a Comparative Analysis of Quantitative Content of Bacterial Endotoxins and Evaluation of Pyrogenicity of the Kazakhstan Vaccine QazCovid-in® against COVID-19 |
K. K. Jekebekov, A. S. Nurpeisova, Zh.S. Abay, K. A. Shorayeva, Zh.S. Absatova, R. T. Abitayev, E. Zh. Kalimolda, S. U. Moldagulova, N. N. Assanzhanova, A. D. Omurtay, Ye.A. Shayakhmetov, S. O. Sadikaliyeva, K. B. Barakbayev, M. M. Kassenov, K. D. Zakarya, Ye.O. Abduraimov |
| 21 |
[GO] |
2024―Feb―29 |
Use of adjuvant compositions based on squalene ensures the induction of neutralizing antibodies against SARS-CoV-2 |
E. A. Volosnikova, N. V. Volkova, V. V. Ermolaev, M. B. Borgoyakova, V. S. Nesmeyanova, A. V. Zaykovskaya, O. V. Pyankov, B. N. Zaitsev, S. V. Belenkaya, A. A. Isaeva, D. N. Shcherbakov |
| 22 |
[GO] |
2024―Feb―12 |
Features of Cytokine and VEGFA Gene Expression Modified with SARS-CoV-2 Virus in an In Vitro Experiment (Using the Example of the SARS-CoV-2 Vaccine Antigen) |
K. G. Starkova, O. V. Dolgikh, I. N. Alikina, O. A. Kazakova, N. A. Nikonoshina, V. B. Alekseev |
| 23 |
[GO] |
2024―Jan―09 |
Analysis of the Morphology of Monocytes and Lymphocytes from COVID-19 Patients Using Low-Voltage Scanning Electronic Microscopy |
A. A. Velmiskina, Yu. V. Nikitin, V. Yu. Mikhailovskii, S. V. Mosenko, A. Yu. Anisenkova, S. V. Apalko, N. N. Sushentseva, S. G. Scherbak, A. M. Ivanov, N. K. Galaktionov, O. V. Shneider, K. A. Kondratov |
| 24 |
[GO] |
2024―Jan―08 |
Features of Distribution of the Allelic Variant of the OAS1 Gene Associated with Severe Form of the Coronavirus Infection in the Russian and Global Populations |
M. V. Olkova, S. M. Koshel, V. S. Petrushenko, A. A. Alimov |
| 25 |
[GO] |
2023―Dec―29 |
Factors of interleukin 6 signalling in COVID-19 patients with varied degree of lung injury: a pilot study |
А. А. Korotaeva, E. V. Samoilova, N. V. Pogosova, D. T. Kuchiev, N. V. Gomyranova, F. N. Paleev |
| 26 |
[GO] |
2023―Dec―29 |
Endothelin level in climacteric women with comorbidity of the acute phase middle severity COVID-19 with arterial hypertension and type 2 diabetes mellitus |
N. V. Semenova, E. V. Vyrupaeva, S. I. Kolesnikov, O. A. Nikitina, L. V. Rychkova, M. A. Darenskaya, A. G. Petrova, L. I. Kolesnikova |
| 27 |
[GO] |
2023―Dec―29 |
Analysis of T-cell and humoral immune response to SARS-CoV-2 antigens in vaccinized combined vector vaccine "Gam-COVID-Vac" in rheumatoid arthritis patients taking rituximab |
V. O. Omelchenko, Yu. D. Kurochkina, A. V. Fedorova, V. S. Ovchinnikov, V. V. Koval, I. V. Bratko, E. A. Letyagina, M. A. Korolev |
| 28 |
[GO] |
2023―Dec―29 |
Delivery of experimental mRNA vaccine, encoding the RBD of SARS-CoV-2 using jet injection |
D. N. Kisakov, L. A. Kisakova, S. V. Sharabrin, V. A. Yakovlev, E. V. Tigeeva, M. B. Borgoyakova, E. V. Starostina, A. V. Zaikovskaya, A. P. Rudometov, N. B. Rudometova, L. I. Karpenko, A. A. Ilyichev |
| 29 |
[GO] |
2023―Nov―18 |
Artificial COVID-19 T-Cell Immunogen |
M. B. Borgoyakova, L. I. Karpenko, A. P. Rudometov, E. V. Starostina, A. M. Zadorozhny, L. A. Kisakova, D. N. Kisakov, S. V. Sharabrin, A. A. Ilyichev, S. I. Bazhan |
| 30 |
[GO] |
2023―Nov―03 |
Ratios between the levels of interleukin 18, free interleukin 18 and interleukin 18 binding protein depending on severity and outcome of COVID-19 |
А. А. Korotaeva, E. V. Samoilova, N. V. Pogosova, A. G. Fesenko, S. V. Evchenko, F. N. Paleev |
| 31 |
[GO] |
2023―Nov―03 |
Safety assessment: a comparative analysis of bacterial endotoxin quantitative content and pyrogenicity determination of the Kazakhstan vaccine QazCovid-in® against COVID-19 |
K. K. Dzhekebekov, A. S. Nurpeisova, Zh. S. Abai, K. A. Shoraeva, Zh. S. Absatova, R. T. Abitaev, E. Zh. Kalimolda, S. U. Moldagulova, N. N. Asanzhanova, A. D. Omurtai, E. A. Shayakhmetov, S. O. Sadikalieva, K. B. Barakbaev, M. M. Kasenov, K. D. Zakarya, E. O. Abduraimov |
| 32 |
[GO] |
2023―Oct―20 |
Ultrastructural Reorganization of Endotheliocytes of Pulmonary Blood Capillaries in COVID-19 |
N. P. Bgatova, S. V. Savchenko, A. N. Lamanov, M. Zh. Ergazina, M. T. Adilova, A. Yu. Letyagin |
| 33 |
[GO] |
2023―Aug―30 |
Distribution features of the OAS1 gene allelic variant associated with a severe form of the coronavirus infection in the Russian and global populations |
M. V. Olkova, S. M. Koshel, V. S. Petrushenko, A. A. Alimov |
| 34 |
[GO] |
2023―Jul―19 |
The Search for Single-Domain Antibodies Interacting with the Receptor-Binding Domain of SARS-CoV-2 Surface Protein |
V. S. Aripov, N. V. Volkova, A. V. Taranin, L. V. Mechetina, N. A. Chikaev, A. M. Nayakshin, V. S. Nesmeyanova, A. A. Isaeva, Yu. A. Merkul’eva, D. V. Shanshin, S. V. Belenkaya, A. A. Ilyichev, D. N. Shcherbakov |
| 35 |
[GO] |
2023―Jun―28 |
Artificial COVID-19 T-cell immunogen |
M. B. Borgoyakova, L. I. Karpenko, A. P. Rudometov, E. V. Starostina, A. M. Zadorozhny, L. A. Kisakova, D. N. Kisakov, S. V. Sharabrin, A. A. Il'ichev, S. I. Bazhan |
| 36 |
[GO] |
2023―Jun―19 |
KDM5 Family Demethylase Inhibitor KDOAM-25 Reduces Entry of SARS-CoV-2 Pseudotyped Viral Particles into Cells |
E. N. Knyazev, R. S. Kalinin, V. A. Abrikosova, Yu.A. Mokrushina, S. A. Tonevitskaya |
| 37 |
[GO] |
2023―Jun―01 |
Ultrastructural reorganization endotheliocytes of pulmonary blood capillaries in COVID-19 |
N. P. Bgatova, S. V. Savchenko, A. N. Lamanov, M. Zh. Ergazina, M. T. Adilova, A. Yu. Letyagin |
| 38 |
[GO] |
2023―Mar―11 |
SARS-CoV-2 Mutations Lead to a Decrease in the Number of Tissue-Specific MicroRNA-Binding Regions in the Lung |
A. P. Zhiyanov, M. Yu. Shkurnikov |
| 39 |
[GO] |
2023―Mar―09 |
Pro-and Antioxidant Status in Newborn with COVID-19 |
L. V. Rychkova, M. A. Darenskaya, A. G. Petrova, N. V. Semenova, E. V. Moskaleva, S. I. Kolesnikov, A. S. Vanyarkina, L. I. Kolesnikova |
| 40 |
[GO] |
2023―Feb―22 |
Search for single-domain antibodies interacting with the receptor-binding domain of SARS-CoV-2 surface protein |
V. S. Aripov, N. V. Volkova, A. V. Taranin, L. V. Mechetina, N. A. Chikaev, A. M. Nayakshin, V. S. Nesmeyanova, A. A. Isaeva, Yu. A. Merkul'eva, D. V. Shanshin, S. V. Belenkaya, A. A. Ilyichev, D. N. Shcherbakov |
| 41 |
[GO] |
2023―Jan―04 |
Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19 |
M. B. Borgoyakova, L. I. Karpenko, I. A. Merkulyeva, D. N. Shcherbakov, A. P. Rudometov, E. V. Starostina, D. V. Shanshin, A. A. Isaeva, V. S. Nesmeyanova, N. V. Volkova, S. V. Belenkaya, E. A. Volosnikova, A. M. Zadorozhny, L. A. Orlova, A. V. Zaykovskaya, O. V. Pyankov, S. I. Bazhan, A. A. Ilyichev |
| 42 |
[GO] |
2022―Nov―04 |
Quantitative Assay of SARS-CoV-2 RNA and Level of Proinflammatory Protein Gene Transcripts in Peripheral Blood Leukocytes after a Novel Coronavirus Infection |
L. V. Topchieva, O. V. Balan, A. V. Men’shenin, I. E. Malysheva, E. L. Tikhonovich |
| 43 |
[GO] |
2022―Nov―02 |
Features of the Humoral Response to Infection, Vaccination, and Revaccination during COVID-19 |
S. Yu. Kombarova, A. V. Aleshkin, L. I. Novikova, S. S. Bochkareva, A. M. Zatevalov, E. R. Mekhtiev, T. E. Mizaeva, A. A. Basov, O. Yu. Borisova, E. I. Likhanskaya, E. A. Voropaeva, Yu. N. Urban, S. D. Mitrokhin, A. S. Shkoda, V. A. Gushchin, A. E. Sinyavin, M. A. Nikiforova, Yu. S. Lebedin, A. V. Karaulov |
| 44 |
[GO] |
2022―Oct―25 |
Pro- and antioxidant status in newborn with COVID-19 |
L. V. Rychkova, M. A. Darenskaya, A. G. Petrova, N. V. Semenova, E. V. Moskaleva, S. I. Kolesnikov, A. S. Vanyarkina, L. I. Kolesnikova |
| 45 |
[GO] |
2022―Oct―10 |
Changes in Spermatogenesis, Lipoperoxidation Processes, and Antioxidant Protection in Men with Pathozoospermia after COVID-19. The Effectiveness of Correction with a Promising Antioxidant Complex |
N. A. Kurashova, B. G. Dashiev, S. I. Kolesnikov, P. S. Dmitrenok, E. P. Kozlovskaya, S. P. Kasyanov, N. V. Epur, V. G. Usov, L. I. Kolesnikova |
| 46 |
[GO] |
2022―Sep―05 |
Mild or Moderate COVID-19 during Pregnancy Does Not Affect the Content of CD34+ Hematopoietic Stem Cells in Umbilical Cord Blood of Newborns |
Yu. A. Romanov, Yu. A. Kosolapova, V. V. Zubkov, D. N. Degtyarev, A. Yu. Romanov, T. N. Dugina, G. T. Sukhikh |
| 47 |
[GO] |
2022―Sep―05 |
Changes in Some Vascular Biomarkers in Patients with Severe COVID-19 with Various Degrees of Pulmonary Hypertension |
D. S. Shilin, K. G. Shapovalov |
| 48 |
[GO] |
2022―Sep―05 |
Cell and Organism Technologies for Assessment of the SARS-CoV-2 Infectivity in Fluid Environment |
A. A. Shelemba, E. A. Kazachkova, Yu. V. Kononova, E. I. Kazachinskaya, M. Yu. Rukavishnikov, I. N. Kuvshinova, M. I. Voevoda, A. M. Shestopalov, A. A. Chepurnov |
| 49 |
[GO] |
2022―Aug―29 |
The immunogenicity of the DNA/protein combinated vaccine against COVID-19 |
M. B. Borgoyakova, L. I. Karpenko, Yu. A. Merkulyeva, D. N. Shcherbakov, A. P. Rudometov, E. V. Starostina, D. V. Shan'shin, A. A. Isaeva, V. S. Nesmeyanova, N. V. Volkova, S. V. Belen'kaya, E. A. Volosnikova, A. M. Zadorozhny, L. A. Orlova, A. V. Zaikovskaya, O. V. P'yankov, S. I. Bazhan, A. A. Il'ichev |
| 50 |
[GO] |
2022―Jul―01 |
Features of the humoral response to infection, vaccination, and revaccination during Covid-19 |
S. Yu. Kombarova, A. V. Aleshkin, L. I. Novikova, S. S. Bochkareva, A. M. Zatevalov, E. R. Mekhtiev, T. E. Mizaeva, A. A. Basov, O. Yu. Borisova, E. I. Likhanskaya, E. A. Voropaeva, Yu. N. Urban, S. D. Mitrokhin, A. S. Shkoda, V. A. Gushchin, A. E. Sinyavin, M. A. Nikiforova, Yu. S. Lebedin, A. V. Karaulov |
| 51 |
[GO] |
2022―Jul―01 |
Quantitative assessment of SARS-CoV-2 RNA and level of pro-inflammatory protein gene transcripts in PBMC after a novel coronavirus infection |
L. V. Topchieva, O. V. Balan, A. V. Men'shenin, I. E. Malysheva, E. L. Tikhonovich |
| 52 |
[GO] |
2022―Jun―23 |
Development of a Test System to Detect the Omicron Variant of SARS-CoV-2 and the Frequency of Its Detection in Patients |
M. L. Filipenko, I. P. Oskorbin, D. V. Shamovskaya, E. A. Kharpov, A. A. Stepanov, V. V. Romanov, V. V. Kuznetsov, U. A. Boyarskikh, A. A. Kechin, E. V. Pechkovsky, A. B. Krivoruchko, A. M. Ivanov, N. E. Kushlinskii, V. V. Vlasov |
| 53 |
[GO] |
2022―Jun―06 |
Changes in spermatogenesis, lipoperoxidation processes and antioxidant protection in men with pathozoospermia after COVID-19 infection. The effectiveness of correction with a promising antioxidant complex |
N. A. Kurashova, B. G. Dashiev, S. I. Kolesnikov, P. S. Dmitrenok, E. P. Kozlovskaya, S. P. Kas'yanov, N. V. Epur, V. G. Usov, L. I. Kolesnikova |
| 54 |
[GO] |
2022―May―28 |
Differences in Characteristics of T-Cell Immunity to SARS-CoV-2 in Clinically Healthy Subjects |
N. N. Sushentseva, O. S. Popov, I. A. Polkovnikova, S. V. Al’pako, S. G. Shcherbak |
| 55 |
[GO] |
2022―May―27 |
Morphofunctional Characteristics of Erythrocytes and Blood Erythropoietin Level in Patients as Predictors of Severe Course of COVID-19 |
V. V. Revin, L. A. Balykova, O. A. Radaeva, V. V. Shchapov, E. S. Revina, S. I. Pinyaev, Yu. A. Kostina, E. D. Kozlov |
| 56 |
[GO] |
2022―May―27 |
Superoxide Dismutase Activity in Male and Female Patients of Different Age with Moderate COVID-19 |
N. V. Semenova, L. V. Rychkova, M. A. Darenskaya, S. I. Kolesnikov, O. A. Nikitina, A. G. Petrova, E. V. Vyrupaeva, L. I. Kolesnikova |
| 57 |
[GO] |
2022―May―27 |
Peculiarities of Humoral Immunity Formation in Medical Institution Employees Recovered from or Vaccinated against COVID-19 in Irkutsk |
V. I. Dubrovina, D. D. Bryukhova, N. O. Kiseleva, M. V. Chesnokova, K. M. Korytov, A. B. Pyatidesyatnikova, V. A. Vishnyakov, S. V. Balakhonov |
| 58 |
[GO] |
2022―May―02 |
Reduced Counts of Various Subsets of Peripheral Blood T Lymphocytes in Patients with Severe Course of COVID-19 |
C. Zhao, X. Hu, Q. Xue, L. Chen |
| 59 |
[GO] |
2022―Apr―28 |
Changes in some vascular biomarkers in patients with severe COVID-19 with various degrees of pulmonary hypertension |
D. S. Shilin, K. G. Shapovalov |
| 60 |
[GO] |
2022―Feb―24 |
Development of a test system to detect the omicron variant of SARS-CoV-2 and the frequency of its detection in patients |
M. L. Philipenko, I. P. Oskorbin, D. V. Shamovskaya, E. A. Kharpov, A. A. Stepanov, V. V. Romanov, V. V. Kuznetsov, U. A. Boyarskikh, A. A. Kechin, E. V. Pechkovsky, A. B. Krivoruchko, A. M. Ivanov, N. E. Kushlinsky, V. V. Vlasov |
| 61 |
[GO] |
2022―Jan―25 |
Morphofunctional characteristics of erythrocytes and blood erythropoietin level in patients as predictors of severe COVID-19 |
V. V. Revin, L. A. Balikova, O. A. Radaeva, V. V. Shchapov, E. S. Revina, S. I. Pinyaev, Yu. A. Kostina, E. D. Kozlov |
| 62 |
[GO] |
2022―Jan―25 |
Superoxide dismutase activity in patients of different sex and age with middle severity COVID-19 |
N. V. Semenova, L. V. Richkova, M. A. Darenskaya, S. I. Kolesnikov, O. A. Nikitina, A. G. Petrova, E. V. Virupaeva, L. I. Kolesnikova |
| 63 |
[GO] |
2022―Jan―25 |
Peculiarities of humoral immunity formation among medical institution employees that have been recover or vaccinated against COVID-19 in Irkutsk |
V .I. Dubrovina, D. D. Bryukhova, N. O. Kiseleva, M. V. Chesnokova, K. M. Korytov, A. B. Pyatidesyatnikova, V. A. Vishnyakov, S. V. Balakhonov |
| 64 |
[GO] |
2022―Jan―08 |
The Role of Na+/K+-ATPase in the Development of Hyponatrenemia under Conditions of Hypoxic Stress in Patients with SARS-CoV-2 Infection |
S. H. Jafarova, S. A. Adnaev, R. T. Guliyeva, N. H. Jafar |
| 65 |
[GO] |
2021―Nov―18 |
Morphometric Parameters of Placental Villi in Parturient Women with COVID-19 |
A. I. Shchegolev, G. V. Kulikova, U. N. Tumanova, R. G. Shmakov, G. T. Sukhikh |
| 66 |
[GO] |
2021―Nov―18 |
Evaluation of the Anti-Viral Activity of Human Recombinant Interferon Lambda-1 against SARS-CoV-2 |
P. G. Madonov, V. A. Svyatchenko, S. S. Legostaev, N. A. Kikhtenko, A. A. Kotlyarova, L. A. Oleinik, G. I. Baikalov |
| 67 |
[GO] |
2021―Nov―17 |
Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology |
A. A. Chepurnov, E. I. Kazachinskaya, E. A. Kazachkova, K. A. Sharshov, Yu. V. Kononova, A. A. Shelemba, A. Yu. Alekseev, M. A. Gulyeva, M. I. Voevoda, A. M. Shestopalov |
| 68 |
[GO] |
2021―Sep―30 |
The role of Na+/K+-ATPase in the development of hyponatrenemia under hypoxic stress in patients with SARS-CoV-2 |
S. H. Jafarova, S. A. Adnaev, R. T. Guliyeva, N. H. Jafar |
| 69 |
[GO] |
2021―Sep―20 |
The State of Microcirculatory Hemodynamics in Patients with Moderate and Severe COVID-19 |
B. I. Kuznik, Yu. N. Smolyakov, Yu. K. Shapovalov, K. G. Shapovalov, S. A. Lukyanov, D. S. Parts |
| 70 |
[GO] |
2021―Aug―02 |
Increased numbers of syncytial knots and high VEGF expression levels in placental villi among parturient women with COVID-19 depend on the disease severity |
A. I. Shchegolev, G. V. Kulikova, U. N. Tumanova, R. G. Shmakov, G. T. Sukhikh |
| 71 |
[GO] |
2021―Aug―02 |
Development of a purified viral preparation for research of COVID-19 (SARS-CoV-2) biology |
A. A. Chepurnov, E. I. Kazachinskaya, E. A. Kazachkov, K. A. Sharshov, Yu. V. Kononova, A. A. Shelemba, A. Yu. Alekseev, M. A. Gulyaeva, M. I. Voevoda, A. M. Shestopalov |
| 72 |
[GO] |
2021―Aug―02 |
Evaluation of the anti-viral activity of the human recombinant interferon lambda-1 against SARS-CoV-2 |
P. G. Madonov, V. A. Svyatchenko, S. S. Legostaev, N. A. Kikhtenko, A. A. Kotlyarova, L. A. Oleynik, G. I. Baykalov |
| 73 |
[GO] |
2021―Jul―22 |
The Number of Syncytial Knots and VEGF Expression in Placental Villi in Parturient Woman with COVID-19 Depends on the Disease Severity |
A. I. Shchegolev, G. V. Kulikova, V. M. Lyapin, R. G. Shmakov, G. T. Sukhikh |
| 74 |
[GO] |
2021―Jun―26 |
Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection |
A. V. Aleshkin, L. I. Novikova, S. S. Bochkareva, S. Yu. Kombarova, Yu. S. Lebedin, A. M. Vorob’ev, E. R. Mekhtiev, E. R. Zul’karneev, A. I. Laishevtsev, A. V. Karaulov |
| 75 |
[GO] |
2021―Apr―27 |
The state of microcirculatory hemodynamics in patients with moderate and severe COVID-19 |
B. I. Kuznik, Yu. N. Smolyakov, Yu. K. Shapovalov, K. G. Shapovalov, S. A. Lukyanov, D. S. Parts |
| 76 |
[GO] |
2021―Mar―22 |
The number of syncytial knots and VEGF expression in placental villi among parturient women with COVID-19 depends on the disease severity |
A. I. Shchegolev, G. V. Kulikova, V. M. Lyapin, R. G. Shmakov, G. T. Sukhikh |
| 77 |
[GO] |
2021―Feb―16 |
Dynamics of antibodies to various antigens of the SARS-CoV-2 coronavirus in patients with confirmed COVID-19 infection |
A. V. Aleshkin, L. I. Novikova, S. S. Bochkareva, S. Iu. Kombarova, Iu. S. Lebedin, A. M. Vorobev, E. R. Mekhtiev, E. R. Zulkarneev, A. I. Laishevtsev, A. V. Karaulov |
|
